PRESS RELEASE published on 04/08/2024 at 14:30, 1 year 11 months ago Jaguar Health Granted Extension Until August 13, 2024, to Regain Compliance with Nasdaq's Bid Price Requirement Jaguar Health, Inc. announces extended grace period from Nasdaq for bid price compliance. Top line results awaited for crofelemer's cancer therapy-related diarrhea prevention trial Crofelemer Nasdaq Jaguar Health Cancer Therapy Grace Period
BRIEF published on 04/02/2024 at 14:35, 1 year 11 months ago Jaguar Health, Inc. Announces Appointment of European Pharmaceutical Industry Veteran as President of Jaguar International Pharmaceutical Industry Crofelemer Jaguar Health Massimo Radaelli Commercial Expansion
BRIEF published on 04/02/2024 at 14:35, 1 year 11 months ago Jaguar Health, Inc. annonce la nomination d'un vétéran de l'industrie pharmaceutique européenne au poste de président de Jaguar International Crofelemer Expansion Commerciale Industrie Pharmaceutique Santé Jaguar Massimo Radaelli
PRESS RELEASE published on 04/02/2024 at 14:30, 1 year 11 months ago Jaguar Health Appoints European Pharmaceutical Industry Leader as President of Jaguar International Dr. Massimo Radaelli appointed as President of Jaguar International to expand commercial footprint globally with recent out-license agreement. Key pharmaceutical industry leader with vast experience and expertise Pharmaceutical Industry Jaguar Health International Expansion Massimo Radaelli Out-license Agreement
BRIEF published on 04/01/2024 at 14:05, 1 year 11 months ago Jaguar Health Reports Financial Downturn in 2023 Results Financial Results Revenue Decline Jaguar Health Mytesi Phase 3 Trial
BRIEF published on 04/01/2024 at 14:05, 1 year 11 months ago Jaguar Health annonce un ralentissement financier dans ses résultats 2023 Résultats Financiers Mytesi Baisse Des Revenus Santé Jaguar Essai De Phase 3
PRESS RELEASE published on 04/01/2024 at 14:00, 1 year 11 months ago Jaguar Health Reports 2023 Financial Results Jaguar Health, Inc. reports an 18% decrease in net revenue for 2023 compared to 2022. Phase 3 OnTarget trial details and upcoming investor webcast disclosed Financial Results Investor Webcast Jaguar Health Inc. Net Revenue Phase 3 OnTarget Trial
BRIEF published on 03/27/2024 at 13:35, 1 year 11 months ago Jaguar Health, Inc. Schedules Investor Webcast for Q4 2023 Financial Review and Updates Pharmaceuticals Investor Webcast Jaguar Health Financials Corporate Update
BRIEF published on 03/27/2024 at 13:35, 1 year 11 months ago Jaguar Health, Inc. programme une webémission pour les investisseurs pour l'examen financier et les mises à jour du quatrième trimestre 2023 Mise À Jour De L'entreprise Médicaments Données Financières Santé Jaguar Webdiffusion Pour Les Investisseurs
PRESS RELEASE published on 03/27/2024 at 13:30, 1 year 11 months ago Jaguar Health to Hold Investor Webcast Monday, April 1st at 8:30 AM Eastern Regarding Q4 2023 Financials & Corporate Updates Jaguar Health, Inc. (NASDAQ:JAGX) will conduct an investor webcast on April 1, 2024, at 8:30 a.m. EST to review fourth-quarter financials and corporate updates. Company plans to file its Earnings Report on Form 10-K for year ended December 31, 2023 Earnings Report Investor Webcast Jaguar Health Financials Form 10-K
Published on 03/25/2026 at 12:55, 10 minutes ago EonX Technologies Reports FY2025 Record Revenue Growth and First Full-Year Profit
Published on 03/25/2026 at 12:30, 35 minutes ago Gold Basin Announces Termination of Charles Straw for Cause
Published on 03/25/2026 at 12:00, 1 hour 5 minutes ago AIML Subsidiary NeuralCloud Enters Research Services Agreement with Baker Heart and Diabetes Institute to Support AI-Driven ECG Analysis
Published on 03/25/2026 at 08:01, 5 hours 4 minutes ago Apex Critical Metals Appoints Zayn Kalyan to Board of Directors
Published on 03/25/2026 at 04:50, 8 hours 15 minutes ago Arctic Fox Announces Closing of First Tranche of Non-Brokered Private Placement
Published on 03/25/2026 at 12:55, 10 minutes ago EQS-Adhoc: Kontron AG: Kontron AG resolves on a new Share Buyback Program I 2026 for own shares
Published on 03/25/2026 at 12:50, 15 minutes ago Prodigy Technovations Enhances Industry leading I3C Protocol Exerciser and Analyzer with Advanced Application-Level Protocol NVMe-MI, SPDM and PLDM Support
Published on 03/25/2026 at 12:05, 1 hour ago Global Mobility Call 2026: The Global Benchmark for the Future of Mobility
Published on 03/25/2026 at 11:10, 1 hour 55 minutes ago MGI Tech Brings High-Throughput T7+ Sequencer to European Market at Analytica 2026 Debut
Published on 03/25/2026 at 08:45, 4 hours 20 minutes ago Air Liquide inaugurates its first Advanced Materials manufacturing plant in Taiwan, strengthening the next-gen semiconductor supply chain
Published on 03/25/2026 at 08:45, 4 hours 20 minutes ago Air Liquide inaugure sa première usine de production de Matériaux Avancés à Taïwan, renforçant ainsi la chaîne d'approvisionnement en semi-conducteurs de nouvelle génération
Published on 03/25/2026 at 07:00, 6 hours 5 minutes ago TINC invests in large-scale battery storage to strengthen the flexibility of the Belgian electricity network (B)
Published on 03/25/2026 at 07:00, 6 hours 5 minutes ago TINC investeert in grootschalige batterijopslag ter versterking van de flexibiliteit van het Belgische stroomnetwerk (B)
Published on 03/25/2026 at 07:00, 6 hours 5 minutes ago TINC invests in large-scale battery storage to strengthen the flexibility of the Belgian electricity network (B)